A company still losing money with steady sales, with elevated risk. Institutions are adding.
Facts from SEC filings, not a recommendation.
Last 12 months: $13.9M, up 11% from the 12 months before.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, profitable every year, share count not growing. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions added 27.6% to their holdings. 37 bought, 13 sold. 4 quarters of net buying in a row.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
878,734 shares at $5.69 · $5.0M
7,983,212 shares
1,757,469 shares at $5.69 · $10.0M
878,734 shares at $5.69 · $5.0M
61,068 shares at $6.73 · $411K
81,300 shares at $6.09 · $495K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page